PINACH, Silvia Vittoria
PINACH, Silvia Vittoria
SCIENZE MEDICHE
After oral fat load NAFLD subjects and healthy controls show different serum free fatty acid trends.
2014-01-01 R. Gambino; E. Bugianesi; C. Rosso; L. Mezzabotta; S. Pinach; N. Alemanno; F. Saba; M. Cassader
Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation
2019-01-01 Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Paschetta, Elena; De Michieli, Franco; Pinach, Silvia; Framarin, Luciana; Berrutti, Mara; Leone, Nicola; Parente, Renato; Ayoubi Khajekini, Mohammad Taghi; Zarovska, Adriana; Gambino, Roberto
Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies.
2002-01-01 MALLONE R; ORTOLAN E; PINACH S; VOLANTE M; ZANONE MM; BRUNO G; BAJ G; LOHMANN T; CAVALLO-PERIN P; MALAVASI F
Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study
2009-01-01 Burt D; Bruno G; Chaturvedi N; Schalkwijk C; Stehouwer CD; Witte DR; Fuller JH; Pinach S; Perin PC; Gruden G.
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study
2009-01-01 Gruden G; Bruno G; Chaturvedi N; Burt D; Pinach S; Schalkwijk C; Stehouwer CD; Witte DR; Fuller JH; Cavallo Perin P
Anti-HSP70 levels and the metabolic syndrome: the Casale Monferrato Study
2012-01-01 Lorenzati B; Giunti S; Barutta F; PInach S; Cavallo Perin P; Bruno G; Gruden G
Association between serum heat shock proteins and anti-heat shock proteins levels with micro/macrovascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study
2007-01-01 Burt D; Bruno G; Chaturvedi N; Stehouwer CD; Pinach S; Witte D; Fuller JH; Cavallo Perin P; Gruden G.
Associazione tra anti-HSP70 e sindrome plurimetabolica: il Casale Monferrato Study
2012-01-01 Lorenzati B; Giunti S; Barutta F; Pinach S; Amione C; Tricarico M; Landi A; Schimmenti A; Cavallo Perin P; Bruno G; Gruden G
ATTIVAZIONE DEL RECETTORE CB2 E NEFROPATIA DIABETICA SPERIMENTALE
2010-01-01 Barutta F; Gambino R; Pinach S; Cavallo Perin P; Gruden G
Calcolo del rischio cardiovascolare nei pazienti diabetici.
2000-01-01 G.Ruiu; G.Grassi; G.Bruno; S.Pinach; G.Gagliardi; L.Monge; G.Giliberto; P.Suppo; G.Aime; M.Cassader; R.Gambino; R.Pagni; G.Maghenzani; G.Pagano
Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy
2010-01-01 Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G.
Circulating anti-Hsp70 levels in nascent metabolic syndrome: the Casale Monferrato Study.
2013-01-01 Gruden G; Barutta F; Pinach S; Lorenzati B; Cavallo-Perin P; Giunti S; Bruno G.
Clinical characteristics and outcome of pregnancy in women with gestational hyperglycaemia with and without antibodies to beta-cell antigens.
2003-01-01 Bo S; Menato G; Pinach S; Signorile A; Bardelli C; Lezo A; Marchisio B; Gentile L; Cassader M; Massobrio M; Pagano G.
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice
2014-01-01 Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load
2016-01-01 Gambino, Roberto; Bugianesi, Elisabetta; Rosso, Chiara; Mezzabotta, Lavinia; Pinach, Silvia; Alemanno, Natalina; Saba, Francesca; Cassader, Maurizio
Does carvedilol impair insulin sensitivity in heart failure patients without diabetes?
2005-01-01 FERRUA S; BOBBIO M; CATALANO E; GRASSI G; MASSOBRIO N; PINACH S; ROSSI C; VEGLIO M; TREVI G
Effect of CB2 receptor deletion in streptozotocin-induced diabetic mice
2011-01-01 Barutta F; Corbelli A; Pinach S; Rastaldi MP; Cavallo Perin P; Gruden G
Effect of phospholipid curcumin Meriva® on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial
2024-01-01 Musso, Giovanni; Pinach, Silvia; Mariano, Filippo; Saba, Francesca; De Michieli, Franco; Framarin, Luciana; Berrutti, Mara; Paschetta, Elena; Parente, Renato; Lizet Castillo, Yanina; Leone, Nicola; Castellino, Francesca; Cassader, Maurizio; Gambino, Roberto
Effect of the MCP-1/CCR2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes
2009-01-01 Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Cavallo Perin P; Camussi G; Gruden G.
Effects of CB1 Blockade In Experimental Diabetic Nephropathy
2009-01-01 Barutta F; Giunti S; Mastrocola R; Pinach S; Giardino L; Rastaldi MP; Cavallo Perin P; Gruden G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| After oral fat load NAFLD subjects and healthy controls show different serum free fatty acid trends. | 2014 | R. Gambino; E. Bugianesi; C. Rosso; L. Mezzabotta; S. Pinach; N. Alemanno; F. Saba; M. Cassader | |
| Angiotensin II Type 1 Receptor rs5186 Gene Variant Predicts Incident NAFLD and Associated Hypertension: Role of Dietary Fat-Induced Pro-Inflammatory Cell Activation | 2019 | Musso, Giovanni; Saba, Francesca; Cassader, Maurizio; Paschetta, Elena; De Michieli, Franco; Pinach, Silvia; Framarin, Luciana; Berrutti, Mara; Leone, Nicola; Parente, Renato; Ayoubi Khajekini, Mohammad Taghi; Zarovska, Adriana; Gambino, Roberto | |
| Anti-CD38 autoantibodies: characterisation in new-onset type I diabetes and latent autoimmune diabetes of the adult (LADA) and comparison with other islet autoantibodies. | 2002 | MALLONE R; ORTOLAN E; PINACH S; VOLANTE M; ZANONE MM; BRUNO G; BAJ G; LOHMANN T; CAVALLO-PERIN P; MALAVASI F | |
| Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study | 2009 | Burt D; Bruno G; Chaturvedi N; Schalkwijk C; Stehouwer CD; Witte DR; Fuller JH; Pinach S; Perin PC; Gruden G. | |
| ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study | 2009 | Gruden G; Bruno G; Chaturvedi N; Burt D; Pinach S; Schalkwijk C; Stehouwer CD; Witte DR; Fuller JH; Cavallo Perin P | |
| Anti-HSP70 levels and the metabolic syndrome: the Casale Monferrato Study | 2012 | Lorenzati B; Giunti S; Barutta F; PInach S; Cavallo Perin P; Bruno G; Gruden G | |
| Association between serum heat shock proteins and anti-heat shock proteins levels with micro/macrovascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study | 2007 | Burt D; Bruno G; Chaturvedi N; Stehouwer CD; Pinach S; Witte D; Fuller JH; Cavallo Perin P; Gruden G. | |
| Associazione tra anti-HSP70 e sindrome plurimetabolica: il Casale Monferrato Study | 2012 | Lorenzati B; Giunti S; Barutta F; Pinach S; Amione C; Tricarico M; Landi A; Schimmenti A; Cavallo Perin P; Bruno G; Gruden G | |
| ATTIVAZIONE DEL RECETTORE CB2 E NEFROPATIA DIABETICA SPERIMENTALE | 2010 | Barutta F; Gambino R; Pinach S; Cavallo Perin P; Gruden G | |
| Calcolo del rischio cardiovascolare nei pazienti diabetici. | 2000 | G.Ruiu; G.Grassi; G.Bruno; S.Pinach; G.Gagliardi; L.Monge; G.Giliberto; P.Suppo; G.Aime; M.Cassader; R.Gambino; R.Pagni; G.Maghenzani; G.Pagano | |
| Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy | 2010 | Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G. | |
| Circulating anti-Hsp70 levels in nascent metabolic syndrome: the Casale Monferrato Study. | 2013 | Gruden G; Barutta F; Pinach S; Lorenzati B; Cavallo-Perin P; Giunti S; Bruno G. | |
| Clinical characteristics and outcome of pregnancy in women with gestational hyperglycaemia with and without antibodies to beta-cell antigens. | 2003 | Bo S; Menato G; Pinach S; Signorile A; Bardelli C; Lezo A; Marchisio B; Gentile L; Cassader M; Massobrio M; Pagano G. | |
| Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice | 2014 | Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G | |
| Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load | 2016 | Gambino, Roberto; Bugianesi, Elisabetta; Rosso, Chiara; Mezzabotta, Lavinia; Pinach, Silvia; Alemanno, Natalina; Saba, Francesca; Cassader, Maurizio | |
| Does carvedilol impair insulin sensitivity in heart failure patients without diabetes? | 2005 | FERRUA S; BOBBIO M; CATALANO E; GRASSI G; MASSOBRIO N; PINACH S; ROSSI C; VEGLIO M; TREVI G | |
| Effect of CB2 receptor deletion in streptozotocin-induced diabetic mice | 2011 | Barutta F; Corbelli A; Pinach S; Rastaldi MP; Cavallo Perin P; Gruden G | |
| Effect of phospholipid curcumin Meriva® on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial | 2024 | Musso, Giovanni; Pinach, Silvia; Mariano, Filippo; Saba, Francesca; De Michieli, Franco; Framarin, Luciana; Berrutti, Mara; Paschetta, Elena; Parente, Renato; Lizet Castillo, Yanina; Leone, Nicola; Castellino, Francesca; Cassader, Maurizio; Gambino, Roberto | |
| Effect of the MCP-1/CCR2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes | 2009 | Tarabra E; Giunti S; Barutta F; Salvidio G; Burt D; Deferrari G; Gambino R; Vergola D; Pinach S; Cavallo Perin P; Camussi G; Gruden G. | |
| Effects of CB1 Blockade In Experimental Diabetic Nephropathy | 2009 | Barutta F; Giunti S; Mastrocola R; Pinach S; Giardino L; Rastaldi MP; Cavallo Perin P; Gruden G. |